CN118574614A - 治疗sars-cov-2感染的方法 - Google Patents

治疗sars-cov-2感染的方法 Download PDF

Info

Publication number
CN118574614A
CN118574614A CN202280089709.6A CN202280089709A CN118574614A CN 118574614 A CN118574614 A CN 118574614A CN 202280089709 A CN202280089709 A CN 202280089709A CN 118574614 A CN118574614 A CN 118574614A
Authority
CN
China
Prior art keywords
cov
sars
infection
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280089709.6A
Other languages
English (en)
Chinese (zh)
Inventor
M·米勒
G·D·埃瓦尔特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotron Ltd
Original Assignee
Biotron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2021903789A external-priority patent/AU2021903789A0/en
Application filed by Biotron Ltd filed Critical Biotron Ltd
Publication of CN118574614A publication Critical patent/CN118574614A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202280089709.6A 2021-11-24 2022-11-24 治疗sars-cov-2感染的方法 Pending CN118574614A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2021903789A AU2021903789A0 (en) 2021-11-24 Methods of treating sars-cov-2 infection
AU2021903789 2021-11-24
PCT/AU2022/051405 WO2023092180A1 (en) 2021-11-24 2022-11-24 Methods of treating sars-cov-2 infection

Publications (1)

Publication Number Publication Date
CN118574614A true CN118574614A (zh) 2024-08-30

Family

ID=86538440

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280089709.6A Pending CN118574614A (zh) 2021-11-24 2022-11-24 治疗sars-cov-2感染的方法

Country Status (8)

Country Link
US (1) US20250009713A1 (https=)
EP (1) EP4436576A4 (https=)
JP (1) JP2024543259A (https=)
KR (1) KR20240110039A (https=)
CN (1) CN118574614A (https=)
AU (1) AU2022399231A1 (https=)
CA (1) CA3238183A1 (https=)
WO (1) WO2023092180A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115260100B (zh) * 2022-08-08 2023-12-12 赛诺瑞生物医药技术(无锡)有限公司 一种用于制备冠状病毒治疗药物的取代酰基胍类化合物和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ596107A (en) * 2005-06-24 2013-09-27 Biotron Ltd Antiviral compounds and methods
ES2563477T3 (es) * 2007-08-03 2016-03-15 Biotron Limited Composiciones antivirales para tratar la hepatitis C a base de 5-(1-metilpirazol-4-il)2-naftoilguanidina y 2'-C-metiladenosina o 2'-C-metilcitidina
SG11201907034PA (en) * 2017-02-08 2019-08-27 Biotron Ltd Methods of treating influenza
US20220409587A1 (en) * 2019-11-26 2022-12-29 Biotron Limited Methods of treating hiv-1 infection
US11660307B2 (en) * 2020-01-27 2023-05-30 Gilead Sciences, Inc. Methods for treating SARS CoV-2 infections
WO2021207049A1 (en) * 2020-04-06 2021-10-14 Gilead Sciences, Inc. Inhalation formulations of 1'-cyano substituted carbanucleoside analogs

Also Published As

Publication number Publication date
JP2024543259A (ja) 2024-11-20
WO2023092180A1 (en) 2023-06-01
CA3238183A1 (en) 2023-06-01
EP4436576A4 (en) 2025-09-17
KR20240110039A (ko) 2024-07-12
EP4436576A1 (en) 2024-10-02
US20250009713A1 (en) 2025-01-09
AU2022399231A1 (en) 2024-05-23

Similar Documents

Publication Publication Date Title
KR102607599B1 (ko) 인플루엔자의 치료 방법
US12167994B2 (en) Vidofludimus for use in the treatment or prevention of viral diseases
CN111467363A (zh) 索非布韦在制备预防和治疗冠状病毒的药物中的应用
CN118574614A (zh) 治疗sars-cov-2感染的方法
EP3934653B1 (en) Azelastine as antiviral treatment
WO2022088037A1 (zh) Sirtinol在制备预防和治疗冠状病毒的药物中的应用
CN116847854A (zh) 包含岩藻糖基乳糖作为有效成分的抗病毒组合物
CA3052503C (en) Methods of treating influenza
WO2022079496A1 (en) A pharmaceutical composition of nitazoxanide, albendazole and pyrantel and method thereof
US20250000877A1 (en) Composition containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredient for preventing or treating viral infectious diseases
HK40017310A (en) Methods of treating influenza
HK40017310B (en) Methods of treating influenza
HK40062780A (en) Vidofludimus for use in the treatment or prevention of viral diseases
CN117838698A (zh) 奥拉替尼在制备治疗流感病毒感染的药物中的应用
CN120392755A (zh) 氨来占诺在制备治疗或预防呼吸道合胞病毒感染的药物的应用
CN114432283A (zh) Sirtinol在制备预防和治疗冠状病毒的药物中的应用
WO2007040426A1 (en) Antiviral agent

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination